The IDEAL Collaboration: what is this and why do we need it?
在这个客座博客,亲fessor Peter McCulloch introduces theIDEAL Collaboration: Idea, Development, Exploration, Assessment and Long-term study to evaluate surgical innovation.
在这个客座博客,亲fessor Peter McCulloch introduces theIDEAL Collaboration: Idea, Development, Exploration, Assessment and Long-term study to evaluate surgical innovation.
Many approved drugs are often removed from sale because their benefit to harm ratio is not acceptable. Researchpublished todayinBMC Medicinehas investigated why this happens, and Joel Lexchin tells us more in this blog.
World Cancer Dayis an international event that aims to unite the world against cancer. Here at theISRCTN registry, we are showing our support by exploring some of the research we have registered in this field.
4thFebruary marks the annualWorld Cancer Day, which aims to increase awareness about cancer. With the theme ‘We Can. I Can.’, in 2016 it encourages us to engage in specific actions to fight the disease. Guided by that, we highlight some of the latest advances in cancer research, which can help us to move even closer to fighting cancer.
1Last week,BMC Medicineattended thePrince Mahidol Award Conferencein Bangkok to hear the debates regarding priority setting for universal health coverage. Here, we take a look at some of the highlights.
February is ‘American Heart Month’. Drs. Meredith Herzog and Kara Siegrist, cardiac anesthesiologists at Vanderbilt University Medical Center in Nashville, and colleagues ofPerioperative Medicine‘sSection Editor Dr Andrew Shaw, write about heart health and the current challenges and advances the population and health care system face to tackle heart disease.
1